Cooley advised GeneWEAVE Biosciences on its approximately $425 million sale to Roche.
GeneWEAVE is a privately-held in vitro diagnostics company that is advancing clinical microbiology with diagnostic solutions. It helps healthcare providers in the fight against drug-resistant bacteria by enabling impactful surveillance programs, early therapy guidance and successful antibiotic stewardship. Roche Molecular Diagnostics is a subsidiary of F. Hoffman-La Roche, the world's largest biotech company.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.